An Investigation On Medication Compliance Of Anti-platelet Drugs In CHD Patients After PCI And The Analysis Of Influencing Factors

Objective:The study was aim at investigating the medication compliance of anti-platelet drugs treatment and influencing factors of coronary heart disease who are after precutaneous coronary intervention (PCI), and setting uP seientific basiec data, so as to provide a meaningful reference.Methods:3 tertiary hospitals in Shanxi province were selected by random sampling.182 subjects, who had done successful PCI from August to November in 2008, were investigated in a manner of telephone interview when obtained informed consent. Topics covered medication compliance schedule and medication compliance affecting factors schedule, and general demographic information questionnaires. Use questionnaire to investigate patients' medication compliance of anti-platelet and its influencing factors, then compiare the differences between compliance and influencing factors after 6 months and 12 months. All data were analyzed with the SPSS 11.5 statistical analysis methods, including descriptive statistics analysis, general linear model analysis, nonparametric test and confirmatory factor analysis, et al. The influencing factors of taking anti-platelet drug compliance which after PCI 6 months and 12 months were analyzed separately by general linear analysis, the difference between compliance and influencing factors after 6 months and 12 months have been analyzed by rank sum test.Result:(1)6 months after PCI, the rate of fully compliance with prescribed medication was 39.8%, and 44.4% of patients showed good compliance.(2) 12 months after PCI, the rate of fully compliance with prescribed medication was 33.9%, and 54.4% of patients showed good compliance.(3) General linear analysis showed that:6 months after PCI, anti-platelet drugs medication compliance in CHD patients was affected by marriage, occupation, monthly income, medication knowledge, medication beliefs, and support of social and family.12 months after PCI, The compliance of anti-platelet drugs medication compliance was affected by monthly income, medication beliefs, and support of social and family.(4) The Paired rank sum test showed:the differences of medication compliance between 6 months and 12 months after PCI in CHD patients has statistically significance. The same results were obtained on medication knowledge.Conclusions:The compliance of anti-platelet drugs needs to be further improved. The systematic and effective interventions should be scheduled according to different influencing factors in different periods. Discharged patients should be followed up in many ways, continuing to strengthen knowledge of medication and to improve social and family support, building the confidence of must be healthy.